InsightAce Analytic Pvt. Ltd. announces the release of market assessment report on “Global Orphan Drug Market Assessment – Revenue (US$ Mn) Forecast Till 2028”
As per the FDA & EMA, orphan drug are the drugs being used to treat disease with number of cases in US are less than 0.2 Million and not more than 5 in 10,000 people across the EU. Orphan drugs market are recognised as the potential therapeutic market because diseases which are covered under the market are life-threatening diseases. Increasing the research & development and speeding up the clinical research activities by small and mid-size pharmaceutical companies are driving the growth of orphan drug market. For instance, currently, more than 400 orphan drugs are commercially available in the market and around 1000 drugs are undergoing clinical trials.
On the other flip side, the prevalence of patients suffering from rare disorders is less, for instance, According to the survey carried out by QuintilesIMS Institute, only 6,084 rare diseases were reported in the US in 2016, because of this many pharmaceutical industries do not entertain the manufacturing of orphan drugs. Thus, less adoption rate of these drugs restrains the market. However, the various financial and legal incentive provided by the governments and technological advancement expected to fuel the growth of market near the future.
Request for ToC/Proposal: https://www.insightaceanalytic.com/report-details/global-orphan-drugs-market-assessment/#request-for-tocproposal
The orphan drug market is fragmented with presence of many players that operates in Orphan Drug in local as well as international market.
Global Orphan Drug Market reports cover major players like Bristol-Myers Squibb Company, Celgene Corporation, F. Hoffmann-La Roche Ltd, Amgen, Biogen, Bayer, Novartis AG, GlaxoSmithKline plc, Johnson & Johnson, AbbVie Inc, Eli Lilly and Company, Alexion, Pharmaceuticals, Shire, Novo Nordisk, AstraZeneca, Eisai, Daiichi Sankyo, Merck, Teva, Pharmaceutical Industries, Actelion Pharmaceuticals Ltd., Aegerion Pharmaceuticals among others.
Curious about this latest version of report? Obtain Report Details @ https://www.insightaceanalytic.com/report-details/global-orphan-drugs-market-assessment/#request-for-tocproposal
- Global Orphan Drug Market by Drug Type Revenue (US$ Mn) Forecast 2020-2028
- Global Orphan Drug Market Based on Top Selling Drugs Revenue (US$ Mn) Forecast 2020-2028
- Other Top Selling Drugs
- Global Orphan Drug Market Based on Therapy Area (US$ Mn) Forecast 2020-2028
- Central Nervous System
- Other Disease Types
- Global Orphan Drug Market Based on Region Revenue (US$ Mn) Forecast 2020-2028
- Europe Revenue (US$ Mn) Forecast 2020-2028
- Rest of Europe
- North America Revenue (US$ Mn) Forecast 2020-2028
- Asia Pacific Revenue (US$ Mn) Forecast 2020-2028
- Latin America Revenue (US$ Mn) Forecast 2020-2028
- Middle East & Africa Revenue (US$ Mn) Forecast 2020-2028
Why should buy this report:
- To receive a comprehensive analysis of the prospects for Global Orphan Drug Market
- To receive industry overview and future trends Orphan Drug market
- To analyze the Orphan Drug market drivers and challenges
- To get information on Orphan Drug size value/revenue (US$ Mn) forecast till 2028
- Major Investments, Mergers & Acquisition in Orphan Drug industry
For More Information @ https://www.insightaceanalytic.com/report-details/global-orphan-drugs-market-assessment/#request-for-tocproposal
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.